Home » omadacycline » Page 5

Tag Archives: omadacycline

Eravacycline Conference Call: Unrevealing and Disappointing

Posted on by — No Comments ↓

Whatever has become of investigative journalism?  All we read after the Stifel conference call (11/17/2015) is descriptive rehash of information provided by Tetraphase at the conference.  No probing questions that we thought investors would ask who just lost 80% of their money.  No signs of analytical or strategic readjustment at Continue reading Eravacycline Conference Call: Unrevealing and Disappointing→

QIDP Drugs – 4th Edition

Posted on by — No Comments ↓

>>> For the latest QIDP list, please click HERE  <<< Since our last QIDP blog from April 8, 2015, several new drugs have made the list which now includes 41 compounds. Below a table which includes compound, sponsor and development stage (Phase). It also indicates whether a drug has been the topic of a Continue reading QIDP Drugs – 4th Edition→

The Circuitous Route to Phase 3:  Another Chapter in the Fitful Development of PTK-0796

Posted on by — No Comments ↓

When antibiotics change hands, it can be a good thing.  Small companies are often desperate to attract a partner with ‘deep pockets’ to help them finance an expensive late phase development but often have to give up control once the honeymoon period is over.  Such transitions can bring delays because new Continue reading The Circuitous Route to Phase 3:  Another Chapter in the Fitful Development of PTK-0796→